The initiation of an antitrust investigation by the Justice Department into UnitedHealth is a significant legal challenge that can lead to regulatory scrutiny, potential fines, and operational restrictions. Such investigations are viewed negatively by the market, as they can impact the company's future earnings and growth prospects. This news is directly responsible for the downturn in UNH's stock price, reflecting investor concerns over the potential outcomes of the investigation.